Skip to main content
Premium Trial:

Request an Annual Quote

NanoString Technologies Secures $15M Senior Credit Facility

NEW YORK (GenomeWeb News) – NanoString Technologies has received $15 million in debt financing from Oxford Finance and Silicon Valley Bank.

The financing includes a $13 million senior secured term loan and a $2 million revolving line of credit and will be used to fund NanoString's growth and for working capital.

Based in Seattle, NanoString is developing a breast cancer assay based on expression of the PAM50 gene signature. It also makes the nCounter Analysis System, a fully automated digital gene expression tool that can multiplex hundreds of genes per sample and detect and count single molecules.

"This facility further strengthens NanoString's balance sheet, allowing us to continue growing our core life sciences business while aggressively pursuing the diagnostics opportunity," Wayne Burns, CFO of NanoString, said in a statement.

NanoString raised $20 million in a Series D round in November.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.